[Answered] The analysis of archaeological materials A. is a relatively quick procedure. B. is necessary ...

This topic contains a solution. Click here to go to the answer

Author Question: The analysis of archaeological materials A. is a relatively quick procedure. B. is necessary ... (Read 699 times)

saliriagwu

Hero Member
Posts: 537

on: Jul 20, 2018

The analysis of archaeological materials

A. is a relatively quick procedure.
B. is necessary only at sites with architecture.
C. is one of the most important steps in the process.
D. takes place in the stratigraphy.

Question 2

The phenomenon of bioturbation would be studied by a(n)

A. geoarchaeologist.
B. paleobotanist.
C. lithic technologist.
D. ethnographer.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

fraziera112

Sr. Member
Posts: 356

Reply #1 on: Jul 20, 2018

Answer to Question 1

C

Answer to Question 2

A

saliriagwu

Hero Member
Posts: 537

Reply #2 on: Jul 20, 2018

Thanks

fraziera112

Sr. Member
Posts: 356

Reply #3 on: Jul 20, 2018

Welcome

« previous next »

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

GI conditions that will keep you out of the U.S. armed services include ulcers, varices, fistulas, esophagitis, gastritis, congenital abnormalities, inflammatory bowel disease, enteritis, colitis, proctitis, duodenal diverticula, malabsorption syndromes, hepatitis, cirrhosis, cysts, abscesses, pancreatitis, polyps, certain hemorrhoids, splenomegaly, hernias, recent abdominal surgery, GI bypass or stomach stapling, and artificial GI openings.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.